Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Medicare Part D Beneficiaries’ Self-reported Barriers to Switching Plans and Making Plan Comparisons at All
Over half of Medicare beneficiaries in stand-alone Part D plans kept their coverage without comparing plans during the last enrollment period, and many reported not knowing how to switch plans.
Posted in -
Most Medicare Beneficiaries Do Not Compare Prescription Drug Plans – And May Be Sticking with Bad Plans
Over half of Medicare beneficiaries in stand-alone Part D plans kept their coverage without comparing plans during the last enrollment period, and many reported not knowing how to switch plans.
Posted in -
Recent Cohorts Aging into Medicare Use More Counseling and Psychotherapy Than Past Cohorts
More recent cohorts aging into Medicare seek significantly more counseling and psychotherapy than prior cohorts, suggesting that plans must prepare to accommodate the needs of new Medicare entrants.
Posted in -
Out-of-Pocket Costs Are Substantially Lower in Medicare Advantage Than Traditional Medicare
Expected monthly out-of-pocket costs for a typical enrollee were about 18-24% lower in Medicare Advantage in recent years, which likely helped fuel the program’s enrollment surge.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Experts On Medicare and Medicaid
Our Work In Medicare and Medicaid
-
Expected Out-Of-Pocket Costs: Comparing Medicare Advantage With Fee-For-Service Medicare
Expected monthly out-of-pocket costs for a typical enrollee were about 18-24% lower in Medicare Advantage in recent years, which likely helped fuel the program’s enrollment surge.
Categorized in -
The Inflation Reduction Act and Patient Costs for Drugs to Treat Heart Failure
Although previous legislation technically closed the Part D coverage gap, patients still faced mid-year out-of-pocket increases. The Inflation Reduction Act’s standard benefit design eliminates the coverage gap in 2025.
Categorized in -
Opinion: I’m a Doctor in East L.A. and Beverly Hills. I Want to Treat Obesity the Same Way in Both Places
Use of newer anti-obesity medications in any part of town can provide true benefit even if lifestyle changes are harder to implement.
Categorized in -
The CBO Report on Medicare and Anti-Obesity Medications Should Not Be the Final Word
The highly anticipated report contains clues on how Congress may come to a different view on medications like Wegovy and Zepbound.
Categorized in -
How the Next President Should Reform Medicare
If left alone, Medicare Advantage will increasingly push overall costs in Medicare into unsustainable territory. Needed reforms can be phased in over a period of years.
Categorized in -
The Future of Medicare’s Coverage with Evidence Development Policy
Join the USC Schaeffer Center in partnership with the Tufts Center for Evaluation of Value and Risk in Health and the Stanford Byers Center for Biodesign, for a conversation on the future of CED.
Categorized in